Publications by authors named "Meredith Foster"

Claim this Profile
C
Correction: Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis.
Lesley A Inker, Josef Coresh, Yingying Sang, Chi-Yuan Hsu, Meredith C Foster

Clin J Am Soc Nephrol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Systems Pharmacology-Based Digital Twins Approach Supplements Clinical Trial Data for Enzyme Replacement Therapies in Pompe Disease.
Chanchala Kaddi, Mengdi Tao, Silke Bergeler, Kelly George, Hugo Geerts, Meredith Foster

Clin Pharmacol Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acid sphingomyelinase deficiency and Gaucher disease: Underdiagnosed and often treatable causes of hepatomegaly, splenomegaly, and low HDL cholesterol in lean individuals.
Pramod K Mistry, David Cassiman, Simon A Jones, Robin Lachmann, Elena Lukina, Meredith C Foster

Hepatol Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylaxis with recombinant factor IX Fc fusion protein reduces the risk of bleeding and delays time to first spontaneous bleed event in previously untreated patients with haemophilia B: A post hoc analysis of the PUPs B-LONG study.
Beatrice Nolan, Michael Recht, Pablo Rendo, Aletta Falk, Meredith Foster

Eur J Haematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A post hoc analysis of previously untreated patients with severe hemophilia A who developed inhibitors in the PUPs A-LONG trial.
Manuel Carcao, Michele Schiavulli, Roshni Kulkarni, Pablo Rendo, Meredith Foster

Blood Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B.
Amy D Shapiro, Roshni Kulkarni, Margaret V Ragni, Hervé Chambost, Johnny Mahlangu, Meredith C Foster

Blood Adv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma glucosylsphingosine correlations with baseline disease burden and response to eliglustat in two clinical trials of previously untreated adults with Gaucher disease type 1.
M Judith Peterschmitt, Meredith C Foster, Allena J Ji, Marianne B Zajdel, Gerald F Cox

Mol Genet Metab· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isatuximab Plus Carfilzomib and Dexamethasone Versus Carfilzomib and Dexamethasone in Patients with Relapsed Multiple Myeloma: IKEMA Subgroup Analysis by Prior Transplantation.
Thomas G Martin, Marcelo Capra, Mohamad Mohty, Kenshi Suzuki, Hang Quach, Meredith C Foster

Transplant Cell Ther· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effects of eliglustat on skeletal manifestations in clinical trials of patients with Gaucher disease type 1.
Timothy M Cox, Joel Charrow, Elena Lukina, Pramod K Mistry, Meredith C Foster

Genet Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Motor Responses in Pediatric Pompe Disease in the ADVANCE Participant Cohort.
Tina Duong, Priya S Kishnani, Kristina An Haack, Meredith C Foster, James B Gibson

J Neuromuscul Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease.
Mazen M Dimachkie, Richard J Barohn, Barry Byrne, Ozlem Goker-Alpan, Priya S Kishnani, Meredith Foster

Neurology· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutropenia, neutrophilia, and neutrophil-lymphocyte ratio as prognostic markers in patients with metastatic castration-resistant prostate cancer.
Alexander Meisel, Ronald de Wit, Stephane Oudard, Oliver Sartor, Frank Stenner-Liewen, Meredith Foster

Ther Adv Med Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac responses in paediatric Pompe disease in the ADVANCE patient cohort.
Barry J Byrne, Steven D Colan, Priya S Kishnani, Meredith C Foster, Susan E Sparks

Cardiol Young· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isatuximab plus pomalidomide and dexamethasone in frail patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis.
Fredrik Schjesvold, Sara Bringhen, Paul G Richardson, Aurore Perrot, Xavier Leleu, Meredith C Foster

Am J Hematol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results.
Pramod K Mistry, Elena Lukina, Hadhami Ben Turkia, Suma P Shankar, Hagit Baris Feldman, Meredith C Foster

Am J Hematol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.
Hiroyoshi Suzuki, Daniel Castellano, Johann de Bono, Cora N Sternberg, Karim Fizazi, Meredith C Foster

Jpn J Clin Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy outcome in women with Gaucher disease type 1 who had unplanned pregnancies during eliglustat clinical trials.
Elena Lukina, Manisha Balwani, Nadia Belmatoug, Nora Watman, Derralynn Hughes, Meredith C Foster

JIMD Rep· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA Trial.
Michael C Kreissl, Lars Bastholt, Rossella Elisei, Robert Haddad, Ole Hauch, Meredith Foster

J Clin Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating total small solute clearance in patients treated with continuous ambulatory peritoneal dialysis without urine and dialysate collection.
Li Fan, Dominik Steubl, Lesley A Inker, Hocine Tighiouart, Andrew L Simon, Meredith C Foster

Perit Dial Int· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term adverse event profile from four completed trials of oral eliglustat in adults with Gaucher disease type 1.
M Judith Peterschmitt, Selena Freisens, Lisa H Underhill, Meredith C Foster, Grace Lewis

Orphanet J Rare Dis· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of Residual Kidney Function Estimating Equations in Dialysis Patients.
Dominik Steubl, Li Fan, Wieneke M Michels, Lesley A Inker, Hocine Tighiouart, Meredith C Foster

Kidney Med· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes after 8 years of eliglustat therapy for Gaucher disease type 1: Final results from the Phase 2 trial.
Elena Lukina, Nora Watman, Marta Dragosky, Heather Lau, Elsa Avila Arreguin, Meredith C Foster

Am J Hematol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolically Healthy Obesity, Transition to Metabolic Syndrome, and Cardiovascular Risk.
Morgana Mongraw-Chaffin, Meredith C Foster, Cheryl A M Anderson, Gregory L Burke, Nowreen Haq

J Am Coll Cardiol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of ESRD and Mortality Associated With Change in Filtration Markers.
Casey M Rebholz, Lesley A Inker, Yuan Chen, Menglu Liang, Meredith C Foster

Am J Kidney Dis· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Association of Percent Body Fat and Lean Mass With HbA in US Adults.
Julie K Bower, Rachel J Meadows, Meredith C Foster, Randi E Foraker, Abigail B Shoben

J Endocr Soc· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis